MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...

At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial ...

Bruker Launches Library Update for Mycobacteria, Showcases Workflow Optimization tools like MALDI Biotyper Pilot™, MALDI Biotyper Galaxy™ and novel MSBL Software for MALDI-based Functional Resistance ...

BREMEN, Germany--(BUSINESS WIRE)-- Bruker today announces multiple placements of MALDI Biotyper systems for rapid, differentiated and cost-effective microbial identification with various local, state ...

Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...

At the 64th ASMS Conference, Bruker introduces rapifleX™, the highest performance MALDI-TOF/TOF mass spectrometer, which had been shown as work-in-progress to early adopters at HUPO 2015. The rapifleX ...

Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

GENEVA--(BUSINESS WIRE)--At the 4 th Congress of European Microbiologists (FEMS 2011), Bruker announces the amendment of its exclusive distribution agreement for clinical microbiology for Bruker’s ...

This video shows Daniel Kolarich from Max Planck Institute explaining new method for improved analysis of glycans and glycoproteins. Bruker’s rapifleX TM MALDI Tissuetyper TM system can be used for ...

This is a Sources Sought notice and not a request for quotes. This request is solely for the purpose of conducting market research to enhance VHA s understanding of your company s offered services and ...